137 related articles for article (PubMed ID: 9522998)
1. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity.
D'Auria L; Pietravalle M; Mastroianni A; Ferraro C; Mussi A; Bonifati C; Giacalone B; Ameglio F
Arch Dermatol Res; 1998; 290(1-2):25-7. PubMed ID: 9522998
[No Abstract] [Full Text] [Related]
2. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
Kawachi Y; Otsuka F
J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris.
Czech W; Schaller J; Schöpf E; Kapp A
J Am Acad Dermatol; 1993 Aug; 29(2 Pt 1):210-5. PubMed ID: 8393016
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia.
Wakugawa M; Nakamura K; Hino H; Toyama K; Hattori N; Okochi H; Yamada H; Hirai K; Tamaki K; Furue M
Br J Dermatol; 2000 Jul; 143(1):112-6. PubMed ID: 10886144
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation.
Engineer L; Bhol K; Kumari S; Razzaque Ahmed A
Cytokine; 2001 Jan; 13(1):32-38. PubMed ID: 11145840
[TBL] [Abstract][Full Text] [Related]
7. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
[TBL] [Abstract][Full Text] [Related]
8. Serum eosinophil cationic protein (ECP) in bullous pemphigoid.
Caproni M; Palleschi GM; Falcos D; D'Agata A; Cappelli G; Fabbri P
Int J Dermatol; 1995 Mar; 34(3):177-80. PubMed ID: 7751092
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid.
Tedeschi A; Marzano AV; Lorini M; Balice Y; Cugno M
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):813-7. PubMed ID: 24650303
[TBL] [Abstract][Full Text] [Related]
10. [Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis].
Rapp J; Kósa L; Halász A; Kereki E; Börzsönyi L
Orv Hetil; 2000 Aug; 141(35):1919-22. PubMed ID: 11019593
[TBL] [Abstract][Full Text] [Related]
11. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
[TBL] [Abstract][Full Text] [Related]
12. Lack of expression of interleukin 8 and RANTES in autoimmune bullous skin diseases.
Bornscheuer E; Zillikens D; Schröder JM; Sticherling M
Dermatology; 1999; 198(2):118-21. PubMed ID: 10325455
[TBL] [Abstract][Full Text] [Related]
13. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
14. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
[TBL] [Abstract][Full Text] [Related]
16. Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid.
Schmidt E; Mittnacht A; Schömig H; Dummer R; Bröcker EB; Zillikens D
J Dermatol Sci; 1996 Feb; 11(2):142-7. PubMed ID: 8869035
[TBL] [Abstract][Full Text] [Related]
17. Increased tryptase and myeloperoxidase levels in blister fluids of patients with bullous pemphigoid: correlations with cytokines, adhesion molecules and anti-basement membrane zone antibodies.
D'Auria L; Pietravalle M; Cordiali-Fei P; Ameglio F
Exp Dermatol; 2000 Apr; 9(2):131-7. PubMed ID: 10772387
[TBL] [Abstract][Full Text] [Related]
18. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
Kramer MF; Ostertag P; Pfrogner E; Rasp G
Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
[TBL] [Abstract][Full Text] [Related]
19. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
Tajima K; Katagiri T
Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
[TBL] [Abstract][Full Text] [Related]
20. Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid.
Miyagaki T; Sugaya M; Kagami S; Nakashima H; Ishiura N; Watanabe R; Ohmatsu H; Fujita H; Yazawa N; Kadono T; Fujimoto M; Saeki H; Tamaki K
J Dermatol Sci; 2009 Apr; 54(1):45-7. PubMed ID: 19117730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
